Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Repurposing: An Effective Tool in Modern Drug Discovery
V. S. Kulkarni, V. Alagarsamy, V. Raja Solomon, et al.
Russian Journal of Bioorganic Chemistry (2023) Vol. 49, Iss. 2, pp. 157-166
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Drug repurposing for rare: progress and opportunities for the rare disease community
Anneliene Hechtelt Jonker, Daniel O’Connor, Maria Cavaller-Bellaubi, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 22
The Role of Artificial Intelligence and Machine Learning in Predicting and Combating Antimicrobial Resistance
Hazrat Bilal, Muhammad Nadeem Khan, Sabir Khan, et al.
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 423-439
Open Access | Times Cited: 5
Hydrolysis, Ligand Exchange, and Redox Properties of Vanadium Compounds: Implications of Solution Transformation on Biological, Therapeutic, and Environmental Applications
Rupam Dinda, Eugenio Garribba, Daniele Sanna, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 3
Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
Robert Morris, Rahinatu Ali, Feng Cheng
Current Drug Targets (2024) Vol. 25, Iss. 7, pp. 454-464
Closed Access | Times Cited: 9
Artificial intelligence for drug repurposing against infectious diseases
Anuradha Singh
Artificial Intelligence Chemistry (2024) Vol. 2, Iss. 2, pp. 100071-100071
Open Access | Times Cited: 9
Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing
Rama Rao Malla, V Sathiyapriya, Sree Makena, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1463-1463
Open Access | Times Cited: 8
Multi-target-directed therapeutic strategies for Alzheimer’s disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition
Jeasang Yoo, Jimin Lee, Byeongha Ahn, et al.
Chemical Science (2025)
Open Access | Times Cited: 1
Advances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors
Julian S. Rechberger, Stephanie Toll, Subhasree Biswas, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 439-439
Open Access | Times Cited: 1
Advantages, Challenges, and Impact of Drug Repurposing for Cancer Treatment
Rabia Zafar, Iqra Safdar, Aiman Munir, et al.
IntechOpen eBooks (2025)
Closed Access | Times Cited: 1
Exploring dual applications of gliptins: A potential host-targeted strategy for diabetes and COVID-19 co-morbidity
Aditi Nag, Y.P. Baid, Mudit Tyagi
Medical Hypotheses (2025), pp. 111602-111602
Closed Access | Times Cited: 1
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms
Mary Dayne Sia Tai, Gloria Gamiz-Arco, Aurora Martı́nez
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1275-1291
Open Access | Times Cited: 5
Bioelectric pharmacology of cancer: A systematic review of ion channel drugs affecting the cancer phenotype
Karina Kofman, Michael Levin
Progress in Biophysics and Molecular Biology (2024) Vol. 191, pp. 25-39
Closed Access | Times Cited: 5
Artificial Intelligence/Machine Learning-Driven Small Molecule Repurposing via Off-Target Prediction and Transcriptomics
Mohan Rao, Eric McDuffie, Clifford Sachs
Toxics (2023) Vol. 11, Iss. 10, pp. 875-875
Open Access | Times Cited: 11
Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation
Sanadelaslam S. A. El‐Hddad, Mohamed Hossam Sobhy, Ahmed El‐Morsy, et al.
RSC Advances (2024) Vol. 14, Iss. 19, pp. 13237-13250
Open Access | Times Cited: 4
The evolution of antifungal therapy: traditional agents, current challenges and future perspectives
Cássia Milena de Souza, Bárbara Tavares Bezerra, Daniel Agreda Mellon, et al.
Current Research in Microbial Sciences (2025) Vol. 8, pp. 100341-100341
Open Access
Special Issue “Advances in Drug Discovery and Synthesis”
Lidia Ciccone, Susanna Nencetti
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 584-584
Open Access
Therapeutic Potential of Sodium–Glucose Cotransporter-2 Inhibitors in Nonalcoholic Fatty Liver Disease: A Network Meta-analysis
Kannan Sridharan, Gowri Sivaramakrishnan
American Journal of Therapeutics (2025)
Closed Access
Computational drug repurposing for tuberculosis by inhibiting Ag85 complex proteins
Israini Wiyulanda Iskandar, Astutiati Nurhasanah, Mochammad Hatta, et al.
Narra J (2025) Vol. 5, Iss. 1, pp. e1130-e1130
Closed Access
Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects
Maria Auxiliadora Parreiras Martins, Francisco Veiga, Ana Cláudia Paiva‐Santos, et al.
ACS Pharmacology & Translational Science (2025)
Open Access
Editorial: Latest findings on Leishmania parasites for better vaccine design and drug development
Negar Seyed, Tahereh Taheri, Farhat Afrin, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Celebrating World Cancer Day: Innovative Biological Approaches to Cancer and their Alignment with Sustainable Development Goals (SDGs)
Hamed Kioumarsi, Bolin Liu
Biological Procedures Online (2025) Vol. 27, Iss. 1
Open Access
Epithelial-mesenchymal transition in cancer: A focus on itraconazole, a hedgehog inhibitor
Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, Beena Thazhackavayal Baby, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189279-189279
Open Access
Unraveling a novel therapeutic facet of Etravirine to confront Hepatocellular Carcinoma via disruption of cell cycle
Gouri Nair, G.R. Saraswathy, Jesil Mathew Aranjani, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Afobazole: a potential drug candidate which can inhibit SARS CoV-2 and mimicry of the human respiratory pacemaker protein
Govinda Rao Dabburu, Anjali Garg, Neelja Singhal, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top